It can exist in three forms: full-length IL-33 (FLIL-33), secreted soluble cytokine IL-33 (sIL-33), and nuclear IL-33 (nIL-33), with different implications in tumor immunity that can vary depending on the tumor histotype [22,23,24]. The gene discussed is IL33; the disease is neoplasm.